Thailand IVF Medication Transition Guide After Return - Assisted Reproduction Knowledge Base

Opening: Real consultation scenario

“I had a fresh embryo transfer in Bangkok and brought back a Thai medication list. But my local doctor said he had never heard of this protocol and didn’t dare to continue it directly. Who should I contact for handover? Can the medication be changed? Will it affect implantation?” — This is the type of consultation we encounter every week.

1. Direct Answer: Two Feasible Paths for Medication After Return

The core issue regarding medication after returning from Thailand IVF lies in the continuation of the luteal support protocol. Whether a fresh or frozen embryo is transferred, sufficient and full-course luteal support is required after transfer until placental function is established (usually 8–10 weeks of pregnancy).

Two Paths:

• Path A: Bring the complete medication plan (English or Thai version) issued by the Thai hospital to a reproductive center or gynecology department at a domestic tertiary hospital. A doctor will evaluate and prescribe medications with the same ingredients to continue the original plan.
• Path B: Based on your hormone levels (progesterone, estradiol, HCG) and ultrasound results, a domestic doctor will reformulate a luteal support plan, replacing it with commonly used domestic medications at equivalent doses.

Both methods are feasible, but the conversion must be done by a doctor. Do not calculate or stop medication on your own.

2. Why Does This Problem Occur?

In cross-border assisted reproduction, medication transition is a systemic issue, not an isolated case. There are three fundamental reasons:

1. Drug Registration Differences: Luteal support medications commonly used in Thailand (e.g., Cyclogest suppositories, Lutigest injections, Duphaston tablets) may have products with the same ingredients in China, but the dosage forms, specifications, and brand names differ. For example, Cyclogest 400mg suppositories are common in Thailand, while progesterone sustained-release gel (Crinone) or progesterone injections are common in China. Doctors need to adjust usage and dosage based on the dosage form.
2. Prescription Authority: The Thai doctor’s plan is based on hormone levels and endometrial conditions during the transfer cycle. If a domestic doctor takes over without complete medical records, it is difficult to assess the logic of the original plan, and they tend to switch to a plan they are familiar with.
3. Patient Information Asymmetry: Most patients only bring back a simple medication list, lacking key information such as laboratory test results, endometrial thickness records, transfer date, and embryo development day. This prevents domestic doctors from evaluating the appropriateness of the original plan.

3. Doctor’s Perspective: The Logic of Domestic Reproductive Doctors Taking Over

Having communicated with reproductive medicine consultants with 10 years of experience and several doctors from tertiary hospital reproductive departments, domestic doctors typically make decisions in the following priority order when handling medication for patients returning from Thailand IVF:

• Priority 1: Confirm pregnancy status. Use blood HCG and ultrasound to determine if pregnant, intrauterine or ectopic, single or multiple. This determines the intensity and duration of subsequent medication.
• Priority 2: Assess luteal function. Check progesterone (P) and estradiol (E2), combined with endometrial thickness, to determine if current luteal support is adequate.
• Priority 3: Align with the original plan. If the patient brings complete Thai medical records, medication logs, and test reports, the doctor will try to continue the original plan with minimal changes.
• Priority 4: Replace with an equivalent plan. If the original medication is unavailable in China or the patient cannot obtain it, the doctor will choose a domestic alternative at an equivalent dose.

What doctors fear most is patients adjusting doses or stopping medication on their own, as well as missing medication records leading to duplicate doses or missed doses.

4. Practical Process: 5 Steps for Medication After Return

5. Timing: Stages and Rhythm of Luteal Support

Regardless of whether in Thailand or China, the duration of luteal support depends on the transfer type and pregnancy outcome:

• Fresh embryo transfer without pregnancy: Menstruation occurs 3–7 days after stopping medication; luteal support lasts about 2 weeks.
• Frozen embryo transfer (artificial cycle): Luteal support usually needs to continue until 10–12 weeks of pregnancy.
• Fresh embryo transfer with pregnancy: Continue medication until 8–10 weeks of pregnancy, then gradually taper off once the placenta produces sufficient progesterone.

Key time points after return are: Day 7–9 post-transfer (pregnancy test day) and Day 14–16 post-transfer (confirm intrauterine pregnancy). These two milestones require tests in China and feedback to the doctor to decide whether to adjust medication.

6. Most Easily Overlooked Details

• Medication Storage Conditions: Progesterone suppositories and gels usually require storage below 25°C, away from light. If checked in during summer return flights, the cargo hold temperature may exceed 30°C, causing the medication to melt or become ineffective. Carry them in hand luggage, and use an insulated bag with ice packs if necessary (confirm if the medication allows refrigeration).
• Dose Unit Conversion: Thailand commonly uses “mg,” while some domestic medications use “g” or “IU.” For example, progesterone injections in China are 20mg/ml, while in Thailand they may be 50mg/ml. Conversion errors can lead to dose deviations.
• Synchronize Medication Records: Use a table to record each medication time, dose, site (for injections), and adverse reactions. Take photos for records and show them directly to the doctor during follow-ups.
• Dydrogesterone and Progesterone Are Not Interchangeable: Dydrogesterone is a synthetic progestin that does not directly raise blood progesterone levels but acts on endometrial receptors. If a domestic doctor only checks blood progesterone levels, they may mistakenly conclude the plan is ineffective.

7. Most Common Pitfalls

8. Country Differences: Comparison of Commonly Used Medications in Thailand vs. China

The above are examples of common protocols. Actual substitution must be determined by a doctor based on individual circumstances.

9. Special Situation Management

9.1 Vaginal bleeding during medication

Light brown or pink blood is common during embryo implantation (5–9 days post-transfer). Continue medication and observe. If bleeding exceeds menstrual flow or is accompanied by abdominal pain, seek immediate medical attention, and do not stop luteal support medication on your own until the doctor rules out ectopic pregnancy or miscarriage.

9.2 Severe bloating or nausea after medication

This may be OHSS (Ovarian Hyperstimulation Syndrome) or a side effect of luteal support medication. Blood routine, coagulation function, and liver/kidney function tests may be needed to assess whether to reduce the dose or switch to another dosage form. For local induration caused by progesterone injections, consider switching to oral or vaginal progesterone.

9.3 Unable to obtain original Thai medication in China

You can apply for imported medication through the hospital pharmacy, but the process is lengthy (2–4 weeks). A more practical approach is to have a domestic doctor prescribe an equivalent domestic medication. If you insist on the original medication, you can contact the Thai hospital for mailing (check customs policies), but the timeline is unpredictable.

10. Frequently Asked Questions

• Q: Do I need injections for medication after returning from Thailand IVF?
  A: Not necessarily. Luteal support comes in oral, vaginal, and injectable forms. Thailand commonly uses vaginal suppositories or gels, but domestic doctors may switch to injections depending on your hormone levels and preferences. Injections offer the most stable absorption but require daily hospital visits or self-injection.
• Q: Which is better, dydrogesterone or progesterone?
  A: There is no absolute superiority. Dydrogesterone does not directly raise blood progesterone levels but has high affinity for endometrial receptors; progesterone directly supplements progesterone, and blood levels can be monitored. The choice depends on the doctor’s preference and your individual situation.
• Q: Can I use the medication brought from Thailand until I am 3 months pregnant?
  A: Not recommended. Medications have expiration dates, and after 8–10 weeks of pregnancy, the placenta gradually takes over luteal function, requiring gradual dose reduction. Regular follow-ups are necessary, and the doctor will decide when to stop.
• Q: Should I see a gynecologist or a reproductive specialist after returning?
  A: A reproductive specialist is preferred. They are more familiar with post-IVF luteal support plans and how to align with overseas protocols. If a reproductive specialist is unavailable, a gynecologist can also help, but bring complete medical records.

11. Practitioner’s Observation

As an overseas coordinator in the assisted reproduction industry, the most common issue I see is not the medication itself, but communication gaps. Patients think “the Thai doctor’s word is final,” while domestic doctors feel “without my signature, I can’t take responsibility.” The result is that patients run back and forth, and medication gaps occur.

A more practical approach is: when seeing the Thai doctor, clearly state, “I will need a domestic doctor to take over after returning,” and proactively ask the Thai doctor to write a detailed medication explanation, including the reason for each medication, target dose, tapering plan, and monitoring indicators. This explanation is more useful than any translation software.

Additionally, some domestic reproductive centers have established “post-overseas IVF follow-up clinics” specifically for such transition issues. Before departure, check if such services are available in your city.

Author: Overseas Assisted Reproduction Coordinator, 8 years of experience, handled 1200+ cross-border cases. Content is based on common clinical issues and is not a substitute for individual medical advice. Please follow the prescribing doctor’s judgment for specific medication plans.